PCH(PCH)
PCH
$41.73—Stale · unknown old
NASDAQ • Last print unknown ago
$41.73—Stale · unknown old
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $1.08B | $1.17B | $1.05B |
| Low | $1.02B | $1.16B | $995M |
| High | $1.15B | $1.17B | $1.12B |
| EBITDA Avg | $203M | $281M | $263M |
| Low | $196M | $246M | $256M |
| High | $216M | $326M | $277M |
| EBIT Avg | $94M | $172M | $156M |
| Low | $87M | $136M | $149M |
| High | $107M | $217M | $170M |
| Net Income Avg | $61M | $132M | $117M |
| Low | $54M | $99M | $110M |
| High | $72M | $172M | $129M |
| EPS Avg | $0.78 | $1.68 | $1.50 |
| Low | $0.68 | $1.25 | $1.39 |
| High | $0.91 | $2.17 | $1.63 |
| Analysts (Rev / EPS) | 5 / 4 | 4 / 3 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $292M | $283M | $300M | $301M | $326M | $313M |
| Low | $292M | $283M | $300M | $301M | $326M | $313M |
| High | $292M | $283M | $300M | $301M | $326M | $313M |
| EBITDA Avg | $56M | $52M | $55M | $55M | $63M | $46M |
| Low | $56M | $52M | $55M | $55M | $63M | $46M |
| High | $56M | $52M | $55M | $55M | $63M | $46M |
| EBIT Avg | $30M | $26M | $29M | $29M | $37M | $19M |
| Low | $30M | $26M | $29M | $29M | $37M | $19M |
| High | $30M | $26M | $29M | $29M | $37M | $19M |
| Net Income Avg | $24M | $20M | $23M | $23M | $30M | $14M |
| Low | $24M | $20M | $23M | $23M | $30M | $14M |
| High | $24M | $20M | $23M | $23M | $30M | $14M |
| EPS Avg | $0.31 | $0.25 | $0.29 | $0.29 | $0.38 | $0.18 |
| Low | $0.31 | $0.25 | $0.29 | $0.29 | $0.38 | $0.18 |
| High | $0.31 | $0.25 | $0.29 | $0.29 | $0.38 | $0.18 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |